UK markets closed

Avenue Therapeutics Inc (49Y0.DU)

Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
6.27+6.19 (+101.37%)
At close: 08:12AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-5,040
-10,377
-3,552
-3,731
-5,151
-
Stock-based compensation
780
906
649
442
710
-
Change in working capital
-370
-290
408
-461
-172
-
Accounts payable
-
-
-
-
-229
-3,233
Other working capital
-4,630
-12,451
-7,596
-3,750
-5,613
-
Other non-cash items
3,959
4,679
530
-
-
61
Net cash provided by operating activities
-4,630
-9,451
-7,596
-3,750
-4,613
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-3,000
-
-
-1,000
-
Purchases of investments
-
-
-
-
0
-5,000
Sales/maturities of investments
-
-
-
-
0
5,000
Net cash used for investing activities
-
-3,000
0
0
-1,000
-
Cash flows from financing activities
Common stock issued
4,424
7,525
11,497
5,044
0
-
Common stock repurchased
-
0
-1,104
0
-
-
Other financing activities
-
-
-508
-663
-
-2,667
Net cash used provided by (used for) financing activities
4,262
7,526
10,541
4,381
0
-
Net change in cash
-368
-4,925
2,945
631
-5,613
-
Cash at beginning of period
585
6,708
3,763
3,132
8,745
-
Cash at end of period
217
1,783
6,708
3,763
3,132
-
Free cash flow
Operating cash flow
-4,630
-9,451
-7,596
-3,750
-4,613
-
Capital expenditure
-
-3,000
-
-
-1,000
-
Free cash flow
-4,630
-12,451
-7,596
-3,750
-5,613
-